| Open | 0 |
| LTP | 0 |
| Previous Close | 0 |
| Day High | 0 |
| Day Low | 0 |
| Volume | 0 |
| Code : | NATPEROX |
| Name : | NATIONAL PEROXIDE LTD. |
| Country : | India |
| Sector : | |
| Industry: | Chemicals |
| Market CAP : | 598 Cr |
| Stock P/E: | 399.75 |
| ROCE: | 0% |
| Book Value: | 1395.69 |
| Dividend Yield : | 1.18% |
| Most Recent Quarter : | 2023-12-31 |
| Revenue/Sales TTM : | 165 Cr |
| Operating Margin TTM : | -0.0231% |
| Return On Equity TTM : | 0% |
| Profit Margin : | 0.01% |
| Market Capitalization : | 598 Cr |
| EBITDA : | 8 Cr |
| Book Value : | 1395.69 |
| PERatio : | 399.75 |
| Dividend Share : | 12.5 |
| Earnings Share : | 2.6 |
| Gross Profit TTM : | 75 Cr |
| Quarterly Earnings Growth YOY : | -0.83% |
| Dividend Yield : | 0.0118% |
| Quarterly Revenue GrowthYOY : | -0.47 |
| Diluted Eps TTM : | 2.6 |
| Trailing PE : | 399.75 |
| Price Sales TTM : | 266.29 |
| Enter Prise Value : | 502 Cr |
| Enter Prise Value Ebidta : | 89562.8714 |
| Forward PE : | 0 |
| Price Book MRQ : | 0.58 |
| Enter Prise Value Revenue : | 263.86 |
| Forward Annual Dividend Rate : | 12.5 |
| Payout Ratio : | 0 |
| Ex Dividend Date : | 2020-08-17 |
| Last Split Date : | 2006-05-26 |
| Forward Annual Dividend Yield : | 0.0064 |
| Dividend Date : | |
| Last Split Factor : | 100:10 |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fibonacci | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Camarilla | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Classic | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days 50 Day MA |
1979.09 |
| Days 200 Day MA |
1983.3 |
| Days 52 Week High |
1080 |
| Days 52 Week Low |
873 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Dec 2023 | 1 Cr | 50 Lac | 53 Lac | 0 | 0 | 5 Lac | 0 | 0 | 0 |
| Sep 2023 | 28 Lac | 32 Lac | -2 Lac | 0 | 0 | -2 Lac | 0 | 0 | 0 |
| Jun 2023 | 80 Cr | 75 Cr | 4 Cr | 0 | 32 Lac | 1 Cr | 0 | 0 Cr | 0 |
| Mar 2023 | -286 Cr | -263 Cr | 343 Cr | 0 | 1 Cr | -10 Cr | 0 | 5 Cr | 0 |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2023 | 2 Cr | 2 Cr | 375 Cr | 0 | 6 Cr | 84 Lac | 14 k | 14 k | 0 |
| Mar 2022 | 29 Lac | 3 Cr | 5 Cr | 0 | 3 Cr | 87 Lac | 0 | 0 | 0 |
| Mar 2021 | 215 Cr | 186 Cr | 21 Cr | 0 | 4 Cr | -9 Cr | 11 Cr | 7 Cr | 0 |
| Mar 2020 | 191 Cr | 176 Cr | 18 Cr | 23 Cr | 5 Cr | 12 Cr | 17 Cr | 21 Cr | 12 Cr |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Sep 2023 | 871 Cr | 4 Cr | 0 | 6 Cr | 0 | 2 Cr | 865 Cr |
| Mar 2023 | 559 Cr | 3 Cr | 0 | 1 Cr | 0 | 1 Cr | 557 Cr |
| Sep 2022 | 1,121 Cr | 144 Cr | 35 Cr | 163 Cr | 0 | 111 Cr | 959 Cr |
| Mar 2022 | 1,068 Cr | 125 Cr | 29 Cr | 157 Cr | 0 | 108 Cr | 911 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2023 | 559 Cr | 3 Cr | 0 | 1 Cr | 0 | 1 Cr | 557 Cr |
| Mar 2022 | 693 Cr | 124 Cr | 29 Cr | 156 Cr | 0 | 107 Cr | 537 Cr |
| Mar 2021 | 1,263 Cr | 165 Cr | 17 Cr | 196 Cr | 0 | 160 Cr | 1,067 Cr |
| Mar 2020 | 1,058 Cr | 186 Cr | 24 Cr | 256 Cr | 42 Cr | 214 Cr | 802 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Dec 2023 | 0 | 0 | 0 | 0 | 53 Lac | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 | 0 | -2 Lac | 0 | 0 |
| Jun 2023 | 0 | 0 | 0 | 0 | 4 Cr | 0 | 0 |
| Mar 2023 | 0 | 0 | 0 | 0 | 343 Cr | 0 | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2023 | 0 | 3 Cr | 0 | 1 Cr | 375 Cr | 0 | 6 Cr |
| Mar 2022 | 0 | 7 Cr | -12 Cr | 34 Cr | 5 Cr | 17 Cr | 18 Cr |
| Mar 2021 | 0 | 7 Cr | 7 Cr | -7 Cr | 21 Cr | 17 Cr | 23 Cr |
| Mar 2020 | -13 Cr | 45 Cr | 7 Cr | -88 Cr | 18 Cr | 11 Cr | 97 Cr |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 0.00 | 0.00 | 0.00 | 0.00 |
0.00 |
0.00 | 0.00 | 0.00 |
National Peroxide Limited manufactures and sells peroxygens in India. It offers hydrogen peroxide that is used in various industries for chemical synthesis, textile bleaching, paper pulp bleaching, sugar bleaching, non-edible oil bleaching, water and effluent treatment, metallurgy, environmental control, sterilization, and other applications. The company also provides compressed hydrogen gas and per acetic acid; and engages in the investment activities. National Peroxide Limited was founded in 1954 and is headquartered in Mumbai, India.
| Open | 0 |
| LTP | 0 |
| Previous Close | 0 |
| Day High | 0 |
| Day Low | 0 |
| Volume | 0 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Lloyds Steels Industries Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GMR Infrastructure Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3i Infotech Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company WIPRO |
LTP 309.1 |
Change 10.75 |
Gain 3.6 % |
|
Company TCS |
LTP 4156.6 |
Change 120.75 |
Gain 2.99 % |
|
Company BAJAJFINSV |
LTP 1743.3 |
Change 26.3 |
Gain 1.53 % |
|
Company BAJFINANCE |
LTP 7397.15 |
Change 105.5 |
Gain 1.45 % |
|
Company HDFCBANK |
LTP 1666.05 |
Change 23.65 |
Gain 1.44 % |
|
Company TATAMOTORS |
LTP 742.75 |
Change -18 |
Loss -18 % |
|
Company AXISBANK |
LTP 959.3 |
Change -10.9 |
Loss -10.9 % |
|
Company BPCL |
LTP 277.6 |
Change -2.6 |
Loss -2.6 % |
|
Company SBIN |
LTP 753.45 |
Change -5.6 |
Loss -5.6 % |
|
Company ONGC |
LTP 264.05 |
Change -1.75 |
Loss -1.75 % |
Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...
Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...
Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...
The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...
Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...
